// App-Quantinova.ai

A-011 : Preformed Anti-HLA Donor-Specific Antibodies Immunological Risk Assessment: The Importance of HLA Antibody Locus-Specificity

Researchers

Presenter

  • V. Jucaud

Principal Investigators

  • A. Babu

  • D. Briggs

  • N. Krishnan

  • D. Mitchell

  • M. Everly

Medical Centers

  • National Research Institute, Los Angeles, CA

  • University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom

  • NHS Blood and Transplant, Oxford, United Kingdom

  • University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom

  • Warwick Medical School, Coventry, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Basiliximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved